Peruvoside

DB13756ExperimentalSmall molecule

Peruvoside: Overview.

Mechanism: Pharmacologically active on Proto-oncogene tyrosine-protein kinase Src
Curator reviewed
Formula / weight: C₃₀H₄₄O₉ · 548.673 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

CO[C@@H]1[C@@H](O)[C@H](C)O[C@@H](O[C@H]2CC[C@@]3(C=O)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H](CC[C@]43O)C3=CC(=O)OC3)C2)[C@H]1O

Targets

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

366Drug interactionsStructured to mechanism, not free text

1ATC codeIncluding every combination product, plus 10 drug categories

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Peruvoside, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.